When tumour cells—with the ability to invade surrounding healthy tissues and to reach and implant themselves into distant organs—are located in the bile ducts, this is called cholangiocarcinoma.
The cells that line the inside of the bile ducts can transform into malignant cells, causing a “cholangiocarcinoma“, which is the name given to malignant tumours of the bile ducts, either in the intrahepatic or extrahepatic part, including the common bile duct.
The Digestive Tumours Committee is made up of a multidisciplinary team of expert professionals.
The General and Digestive Surgery Service deals with the prevention, diagnosis and treatment of bile duct cancer.
The Service's team of professionals accompanies cancer patients throughout the whole disease process.
A clinical trial is a research study carried out on people with the aim of learning more about how the body reacts to certain treatments. These trials generally seek to find drugs that are more effective than the current best therapeutic option for patients, or that have similar efficacy but a better toxicity profile.
Bearing in mind that almost all currently available treatments are the result of clinical research, the importance of clinical trials is obvious.
The IVO has a clinical trials unit for all types of tumours and participates in phase 1-3 studies as well as other types of studies.
Whether you receive the news of an initial diagnosis of cancer or a relapse, coping with cancer can be emotionally overwhelming. Each person has their own way of coping with a bile duct cancer diagnosis, but there are some recommendations that can help you through this process: